SERPINE1 is a member of the validated five-member EMT- or plasticity-related prognostic gene set in gastric cancer and the six-gene signature that accurately predicts reduced overall survival in patients with HNSCC, where it partitions to the aggressive tumor signature subset, indicative of poor prognosis and higher risk score. This evidence concerns the gene SERPINE1 and head and neck squamous cell carcinoma.